Insmed Incorporated (NAS: INSM) Stock Analysis & Fundamentals

INSMInsmed Incorporated

NAS · US · Healthcare · Biotechnology · insmed.com

107.46USD-2.14%Mkt Cap: 23.29B $P/E: —1d ago

Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory …

Headline	Source	Time
Today
Arbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advances The new lawsuits add to a web of legal disputes over technology involved in COVID vaccines. Elsewhere, a prolific AI biotech inked another deal and Insmed strengthened support for a closely watched blood pressure drug.	BioPharma Dive	6h
Yesterday
Insmed's TPIP Shows Durable PAH Benefits in 12-Month Study Insmed (NASDAQ:INSM) reported 12-month results from an ongoing open-label extension study of TPIP in patients with pulmonary arterial hypertension, saying the data showed sustained efficacy measures and a generally favorable safety profile over longer-term use. TPIP is an inhaled prodrug of trepros	MarketBeat	1d
Older
Here’s Why TimesSquare Mid Cap Growth Strategy Added Insmed (INSM)	Insider Monkey	Jul 1
Mizuho Maintains an Outperform Rating on Insmed Incorporated (INSM)	Insider Monkey	Jun 28
Nebius and CoreWeave fall after Nasdaq 100 listing	Blockspace	Jun 23
Kymera Therapeutics (KYMR) Soars 10.0%: Is Further Upside Left in the Stock?	Zacks	Jun 23
Should Insmed’s (INSM) NASDAQ-100 Exit and TPIP Focus Require Action From Investors?	Simply Wall St.	Jun 23
Is Insmed (INSM) One of the Most Promising Healthcare Stocks After Cantor Fitzgerald’s Target Raise?	Insider Monkey	Jun 22
Incyte Stock: Is INCY Outperforming the Healthcare Sector?	Barchart	Jun 22
Nasdaq-100 Onboards 5 New Stocks in AI-Fueled Rebalancing	The Daily Upside	Jun 22
Dear CoreWeave Stock Fans, Mark Your Calendars for June 22	Barchart	Jun 17
Jim Cramer Says SaaS Companies Like Zscaler “Have Fallen Viciously Out of Favor on Wall Street”	Insider Monkey	Jun 17
Stocks Rally on Hopes for a Near-term US-Iran Interim Peace Agreement	Barchart	Jun 12
Stocks See Support from Hopes for a Near-term US-Iran Peace Agreement	Barchart	Jun 12
Stocks See Support from Hopes for a Near-term US-Iran Agreement	Barchart	Jun 12
Stocks See Downward Pressure Despite Hopes for a Near-term US-Iran Agreement	Barchart	Jun 12
Five AI and Space Names Join the Nasdaq-100	GuruFocus.com	Jun 12
Nasdaq-100 Adds New AI and Space Winners. These Stocks Are Soaring	GuruFocus.com	Jun 12
Is Insmed (INSM) The Best Healthcare Stock to Buy Now?	Insider Monkey	Jun 8
Is Insmed's (INSM) Brensocatib Momentum Quietly Reframing Its Respiratory Growth Narrative?	Simply Wall St.	Jun 6
US Equity Markets End Lower Amid Technology Stock Sell-Off, Stronger-Than-Expected Jobs Data	MT Newswires	Jun 5
Insmed Brinsupri Shows Strong Physician Conviction, Early Launch Momentum, RBC Says	MT Newswires	Jun 5
What Does Cantor Fitzgerald Think About Harrow (HROW) After Cutting Its Price Target?	Insider Monkey	Jun 4
JPMorgan Says Buy the Dip in These 2 Large-Cap Biotech Stocks	TipRanks	Jun 4
A Look At Insmed (INSM) Valuation After Recent Share Price Weakness And Brensocatib Launch Expectations	Simply Wall St.	Jun 2
ATS 2026: Insmed shines in bronchiectasis with spotlight on Brinsupri	Pharmaceutical Technology	Jun 2
NWI Management Dumps 42,700 MercadoLibre Shares Worth $82.4 Million	Motley Fool	May 30
Why This Fund Made a $189 Million Bet on Erasca as Shares Skyrocket 800%	Motley Fool	May 30
Tango Therapeutics Stock Is Up 840%, and This Fund Just Disclosed Buying $164 Million More	Motley Fool	May 30
JPMorgan says large-cap biotech is back as profits and pipelines fuel upside	Investing.com	May 28
JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms	Investing.com	May 20
Competitive Pressures Prompt Truist to Cut Target on Insmed (INSM)	Insider Monkey	May 20
Assessing Insmed (INSM) Valuation After Recent Share Price Pullback And Strong Multi Year Returns	Simply Wall St.	May 19
Insmed CEO Defends BRINSUPRI Launch as Sales Surge, TPIP Pipeline Gains Focus	MarketBeat	May 18
This Nuclear Tech Stock Grew Revenue 27%, But a Fund Still Slashed Its Stake	Motley Fool	May 16
This Trade School Stock Is Up 135%. Here’s Why a Fund Still Bought 459,000 Shares	Motley Fool	May 16
Callaway Stock Has Soared 150%. Here’s Why One Fund Still Bought 1.1 Million Shares	Motley Fool	May 16
Insmed Incorporated (INSM) Reports Q1 2026 Results	Insider Monkey	May 13

Industry Peers